Estructura del grupo
7 empresas en 4 países
Cargando…
7 empresas en 4 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 50
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| BROMANATE DM2mg/5ml; 10mg/5ml; 30mg/5ml · Syrup | Brompheniramine, Dextromethorphan, Pseudoephedrine | Estados Unidos | No comercializado | |
| BROMANYL12.5mg/5ml; 10mg/5ml · Syrup | Bromodiphenhydramine, Codeine | Estados Unidos | No comercializado | |
| BUTABARB30mg/5ml · Elixir | Butabarbital | Estados Unidos | No comercializado | 1978 |
| CHLORPROMAZINE HYDROCHLORIDE10mg/5ml · Syrup | Chlorpromazine | Estados Unidos | No comercializado | 1980 |
| CODAMINE5mg/5ml; 25mg/5ml · Syrup | Hydrocodone, Phenylpropanolamine | Estados Unidos | No comercializado | 2000 |
| EMBEDA100MG; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG; 0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG; 1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG; · Capsule, extended release | Morphine, Naltrexone | Estados Unidos | No comercializado | 2009 |
| ERYTHROMYCIN ESTOLATE125mg base/5ml | 250mg base/5ml · Suspension | Erythromycin | Estados Unidos | No comercializado | 1982 |
| FLUOCET0.025% · Cream | Fluocinolone acetonide | Estados Unidos | No comercializado | |
| HYDRAMINE12.5mg/5ml · Elixir | Diphenhydramine | Estados Unidos | No comercializado | |
| HYDRAMINE12.5mg/5ml · Syrup | Diphenhydramine | Estados Unidos | No comercializado | |
| ISOETHARINE MESYLATE0.34mg/inh · Aerosol, metered | Isoetharine | Estados Unidos | No comercializado | 1984 |
| ISOPROTERENOL HYDROCHLORIDE0.12mg/inh · Aerosol, metered | Isoprenaline | Estados Unidos | No comercializado | 1956 |
| LOMANATE0.025mg/5ml; 2.5mg/5ml · Solution | Atropine, Diphenoxylate | Estados Unidos | No comercializado | |
| METHDILAZINE HYDROCHLORIDE4mg/5ml · Syrup | Methdilazine | Estados Unidos | No comercializado | 1981 |
| MYKINAC100,000 units/gm · Ointment | Nystatin | Estados Unidos | No comercializado | |
| MYKINAC100,000 units/gm · Cream | Nystatin | Estados Unidos | No comercializado | |
| PIPERAZINE CITRATE500mg base/5ml · Syrup | Piperazine | Estados Unidos | No comercializado | 1974 |
| PROCHLORPERAZINE10mg base/ml · Concentrate | Prochlorperazine edisylate | Estados Unidos | No comercializado | 1982 |
| PROMETH FORTIS25mg/5ml · Syrup | Promethazine | Estados Unidos | No comercializado | 1978 |
| SERAX10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Oxazepam | Estados Unidos | No comercializado | 1965 |
| SERAX15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Oxazepam | Estados Unidos | No comercializado | 1965 |
| THEOPHYLLINE150mg/15ml | 80mg/15ml · Syrup | Theophylline | Estados Unidos | No comercializado | |
| THIORIDAZINE HYDROCHLORIDE100mg/ml | 30mg/ml · Concentrate | Thioridazine | Estados Unidos | No comercializado | 1983 |
| TRIMEPRAZINE TARTRATE2.5mg base/5ml · Syrup | Alimemazine | Estados Unidos | No comercializado | |
| TRIMETH/SULFA200mg/5ml; 40mg/5ml · Suspension | Sulfamethoxazole, Trimethoprim | Estados Unidos | No comercializado | 1988 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 26 | 26 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 20 | 20 | 0 | EmpresasTodos los medicamentos |
| Canadá | 4 | 0 | 4 | EmpresasTodos los medicamentos |
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Alpharma en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.